0000914190-19-000169.txt : 20190517 0000914190-19-000169.hdr.sgml : 20190517 20190517160759 ACCESSION NUMBER: 0000914190-19-000169 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190515 FILED AS OF DATE: 20190517 DATE AS OF CHANGE: 20190517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Noseda Alessandro CENTRAL INDEX KEY: 0001777031 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15070 FILM NUMBER: 19835703 MAIL ADDRESS: STREET 1: C/O 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER NAME: FORMER CONFORMED NAME: Noseda Alesandro DATE OF NAME CHANGE: 20190516 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-208-9191 MAIL ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2019-05-15 1 0000707511 REGENERX BIOPHARMACEUTICALS INC RGRX 0001777031 Noseda Alessandro C/O REGENERX BIOPHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 470 ROCKVILLE MD 20850 1 0 0 0 /s/ Andrew Nick as Attorney-in-Fact for Alessandro Noseda pursuant to Power of Attorney filed herewith. 2019-05-17 EX-24 2 nosedapoa.htm NOSEDO POWER OF ATTORNEY

POWER OF ATTORNEY



 The undersigned hereby constitutes and appoints J.J. Finkelstein,

Dane Saglio, Christopher Melsha or Andrew Nick, or either of them acting

alone, the undersigned's true and lawful attorney-in-fact and agent with

full power of substitution and resubstitution, for the undersigned and in

the undersigned's name, place and stead, in any and all capacities, to

sign any or all Forms 4 and Forms 5 relating to beneficial ownership of

securities of RegeneRx Biopharmaceutical, Inc. (the "Issuer"), to file

the same, with all exhibits thereto and other documents in connection

therewith, with the Securities and Exchange Commission and to deliver a

copy of the same to the Issuer, granting unto said attorney-in-fact and

agent full power and authority to do and perform each and every act and

thing requisite and necessary to be done in and about the premises, as

fully to all intents and purposes as the undersigned might or could do in

person, hereby ratifying and confirming all said attorney-in-fact and

agent, or his substitute or substitutes, may lawfully do or cause to be

done by virtue thereof.  The undersigned acknowledges that the foregoing

attorney-in-fact, in serving in such capacity at the request of the

undersigned, is not assuming any of the undersigned's responsibilities to

comply with Section 16 of the Securities Exchange Act of 1934.



 This power of attorney may be revoked as to any attorney-in-fact

upon written notice to that person, which shall be deemed to have been

given if mailed or if transmitted and confirmed by any standard form of

telecommunication, including but not limited to confirmed facsimile and

email transmissions.  Furthermore, this Power of Attorney will be

terminated if at any time the undersigned is no longer subject to the

provisions of Section 16 of the Securities Exchange Act of 1934 with

respect to securities of the Issuer.



 IN WITNESS WHEREOF, the undersigned has caused this Power of

Attorney to be executed as of this 15th day of May, 2019.



     /s/ Alessandro Noseda